En el mundo de la ciencia, hay figuras cuyo impacto trasciende generaciones, y Gregor Johann Mendel es sin duda una de esas personalidades. Conocido como el padre de la genética, Mendel revolucionó nuestra comprensión de la herencia biológica y sentó las bases para …
Tarsus Pharmaceuticals, Inc. announced the pricing of an underwritten public offering of 2,812,500 shares of its common stock at a public offering price of $32.00 per share, and, in lieu of common stock to a certain investor, pre-funded warrants to purchase up to 312,500 shares of its common stock at a public offering price of
Tarsus Announces Pricing of $100.0 Million Public Offering Read More »
Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced today announced the pricing of an underwritten public offering of 13,400,000 shares of its common stock at a public offering price of $3.00 per share.
Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock Read More »
La carrera hacia la minería espacial está cobrando impulso como nunca antes. Lo que una vez fue considerado una fantasía de ciencia ficción está ahora al borde de convertirse en una realidad tangible. Con el rápido avance de la tecnología espacial y l …
Adicet Bio, Inc., a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, announced it granted an inducement award on February 29, 2024.
Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an upsized underwritten public offering of 8,520,000 shares of its common stock at a public offering price of $47.00 per share. All of the shares to be sold in the offering are to be sold by Celldex.
“Síndrome Urémico Hemolítico: Detectar, prevenir y proteger” es la nueva iniciativa de la Sociedad Argentina de Infectología. El doctor Martín Brizuela dialogó con IntraMed sobre la enfermedad, que afecta principalmente a menores de 5 años.
The survey from Berkeley Research Group comes as the federal government mulls how to best regulate artificial intelligence in healthcare.
Three-quarters of health professionals project widespread AI adoption: survey Read More »
Investment returns and outpatient services revenue drove results.
Mayo Clinic boosted operating income by 82% in 2023 Read More »
The device maker will vie against rivals Boston Scientific and Medtronic in the market for the new treatment for atrial fibrillation.
J&J’s pulsed field ablation system secures European approval Read More »
